Your browser doesn't support javascript.
loading
A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4.
Yamaguchi, Takehiro; Watanabe, Ayano; Tanaka, Masako; Shiota, Masayuki; Osada-Oka, Mayuko; Sano, Soichi; Yoshiyama, Minoru; Miura, Katsuyuki; Kitajima, Shojiro; Matsunaga, Shinji; Tomita, Shuhei; Iwao, Hiroshi; Izumi, Yasukatsu.
Afiliación
  • Yamaguchi T; Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan. Electronic address: tayamaguchi-oss@umin.ac.jp.
  • Watanabe A; Applied Pharmacology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Tanaka M; Applied Pharmacology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Shiota M; Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Osada-Oka M; Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan; Food Hygiene and Environmental Health Division of Applied Life Science, Kyoto Prefectural University, Kyoto, Japan.
  • Sano S; Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Yoshiyama M; Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Miura K; Food Hygiene and Environmental Health Division of Applied Life Science, Kyoto Prefectural University, Kyoto, Japan.
  • Kitajima S; Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Matsunaga S; Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Tomita S; Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Iwao H; Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan; Shitennoji University, Osaka, Japan.
  • Izumi Y; Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan; Department of Internal Medicine, Takaishikamo Hospital, Osaka, Japan. Electronic address: izumi@msic.med.osaka-cu.ac.jp.
J Pharmacol Sci ; 139(2): 112-119, 2019 Feb.
Article en En | MEDLINE | ID: mdl-30638989

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inhibidores de la Dipeptidil-Peptidasa IV / Linagliptina / Infarto del Miocardio Límite: Animals Idioma: En Revista: J Pharmacol Sci Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inhibidores de la Dipeptidil-Peptidasa IV / Linagliptina / Infarto del Miocardio Límite: Animals Idioma: En Revista: J Pharmacol Sci Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article